ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
出版年份 2021 全文链接
标题
ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-22
DOI
10.3389/fcell.2021.738364
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness
- (2019) Yin Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression
- (2019) Weipu Mao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
- (2019) Kaili Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cystatin C in Evaluating Renal Function in Ureteral Calculi Hydronephrosis in Adults
- (2019) Weipu Mao et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
- (2018) Joshua I. Warrick et al. EUROPEAN UROLOGY
- Global Burden of Urologic Cancers, 1990–2013
- (2017) Geolani W. Dy et al. EUROPEAN UROLOGY
- Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
- (2017) Jesus García-Donas et al. LANCET ONCOLOGY
- Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer
- (2017) Alana D. Ranzi et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma
- (2015) Mirela S. Petrulea et al. CANCER TREATMENT REVIEWS
- E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease
- (2015) Lan-Hsin Wang et al. DEVELOPMENTAL CELL
- Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro
- (2015) I-TSANG CHIANG et al. ONCOLOGY REPORTS
- Bladder Tumor Heterogeneity: The Impact on Clinical Treatment
- (2015) Chao Chen et al. UROLOGIA INTERNATIONALIS
- Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression
- (2013) Ming Luo et al. FEBS Journal
- The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung Cancer
- (2009) Jérôme Rollin et al. PLoS One
- Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver
- (2008) M J Gray et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started